ESC Professional Premium Access

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Topic: Epidemiology, Prognosis, Outcome

Congress Presentation

About the speaker

Professor Ntobeko Ayanda Bubele Ntusi

University of Cape Town, Cape Town (South Africa)
8 presentations
2 followers

7 more presentations in this session

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Speaker: Doctor M. Ibrahim (Flint, US)

Thumbnail

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Speaker: Professor J. Wang (Shanghai, CN)

Thumbnail

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Speaker: Associate Professor G. Abdullaeva (Tashkent, UZ)

Thumbnail

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Speaker: Doctor E. Manta (Athens, GR)

Thumbnail

Improved health-related quality of life after renal denervation in patients with resistant hypertension: 3-year outcomes in the global symplicity registry

Speaker: Associate Professor F. Mahfoud (Basel, CH)

Thumbnail

Access the full session

Drugs and devices in hypertension

Speakers: Professor N. Ntusi, Doctor M. Ibrahim, Professor J. Wang, Associate Professor G. Abdullaeva, Doctor E. Manta...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations